Circulating microRNAs as biomarkers of adult Crohn's disease

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 9, 2015, Pages 1038-1044

  Jensen, Michael D ^a   Andersen, Rikke F ^a   Christensen, Henry ^a   Nathan, Torben ^a   Kjeldsen, Jens ^b   Madsen, Jonna S ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Crohn disease; microRNAs; plasma

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; HSA LET 7G; HSA MICRORNA 106A; HSA MICRORNA 125A 5P; HSA MICRORNA 140 3P; HSA MICRORNA 181 2; HSA MICRORNA 21; HSA MICRORNA 369 3P; HSA MICRORNA 376; HSA MICRORNA 376A; HSA MICRORNA 376C; HSA MICRORNA 411; MICRORNA; MICRORNA 132; MICRORNA 16; MICRORNA 200C; MMU MICRORNA 379; UNCLASSIFIED DRUG; GENETIC MARKER;

ADOLESCENT; ADULT; ADULT DISEASE; AGED; ARTICLE; CAPSULE ENDOSCOPY; COLONOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; FECES LEVEL; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; ILEOCOLONOSCOPY; MAJOR CLINICAL STUDY; MALE; OPENARRAY SYSTEM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA PURIFICATION; UPREGULATION; VALIDATION STUDY; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; DNA MICROARRAY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; YOUNG ADULT;

EID: 84938945622     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000430     Document Type: Article

References (21)

1. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, et al the second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27
2. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Long-Term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-250
3. Baumgart DC, Sandborn WJ. Crohn's disease. Lancet 2012; 380: 1590-1605
4. Archanioti P, Gazouli M, Theodoropoulos G, Vaiopoulou A, Nikiteas N. Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis 2011; 5: 520-524
5. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20
6. Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease-pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18: 4629-4634
7. Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev 2012; 11: 305-314
8. McKenna LB, Schug J, Vourekas A, McKenna JB, Bramswig NC, Friedman JR, Kaestner KH. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010; 139: 1654-1664
9. Iborra M, Bernuzzi F, Correale C, Vetrano S, Fiorino G, Beltrán B, et al. Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease. Clin Exp Immunol 2013; 173: 250-258
10. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, et al. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010; 16: 1729-1738
11. Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C, et al. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One 2010; 5: e13160
12. Guo Z, Wu R, Gong J, Zhu W, Li Y, Wang Z, et al. Altered microRNAs expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease. J Gastroenterol Hepatol 2015; 30: 109-116
13. Paraskevi A, Theodoropoulos G, Papaconstantinou I, Mantzaris G, Nikiteas N, Gazouli M. Circulating microRNA in inflammatory bowel disease. J Crohns Colitis 2012; 6: 900-904
14. Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011; 53: 26-33
15. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, Bayless TM, et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2011; 17: 241-250
16. Fujioka S, Nakamichi I, Esaki M, Asano K, Matsumoto T, Kitazono T. Serum microRNA levels in patients with Crohn's disease during induction therapy by infliximab. J Gastroenterol Hepatol 2014; 29: 1207-1214
17. Jensen MD, Nathan T, Rafaelsen SR, Kjeldsen J. Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepatol 2011; 9: 124-129
18. Jensen MD, Kjeldsen J, Rafaelsen SR, Nathan T. Diagnostic accuracies of MR enterography and CT enterography in symptomatic Crohn's disease. Scand J Gastroenterol 2011; 46: 1449-1457
19. Witwer KW. Circulating microRNA biomarker studies: pitfalls and potential solutions. Clin Chem 2015; 61: 56-63
20. Tomankova T, Petrek M, Gallo J, Kriegova E. MicroRNAs: emerging regulators of immune-mediated diseases. Scand J Immunol 2012; 75: 129-141
21. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135: 1624-1635